Novelion Therapeutics Inc. (NVLN): Price and Financial Metrics


Novelion Therapeutics Inc. (NVLN): $0.68

-0.02 (-2.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NVLN to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

NVLN Stock Price Chart Interactive Chart >

Price chart for NVLN

NVLN Price/Volume Stats

Current price $0.68 52-week high $2.35
Prev. close $0.70 52-week low $0.54
Day low $0.54 Volume 238,300
Day high $0.68 Avg. volume 190,529
50-day MA $0.72 Dividend yield N/A
200-day MA $0.98 Market Cap 13.34M

Novelion Therapeutics Inc. (NVLN) Company Bio


Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc., which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.


NVLN Latest News Stream


Event/Time News Detail
Loading, please wait...

NVLN Latest Social Stream


Loading social stream, please wait...

View Full NVLN Social Stream

NVLN Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -21.48%
5-year -92.33%
YTD N/A
2021 N/A
2020 N/A
2019 0.00%
2018 -73.08%
2017 -62.95%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.687 seconds.